Logo image of ALGRO.PA

GROLLEAU SACA (ALGRO.PA) Stock Fundamental Analysis

EPA:ALGRO - FR0014005ZM5 - Common Stock

2.86 EUR
+0.02 (+0.7%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

2

ALGRO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ALGRO may be in some trouble as it scores bad on both profitability and health. ALGRO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALGRO had negative earnings in the past year.
In the past year ALGRO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALGRO reported negative net income in multiple years.
Each year in the past 5 years ALGRO had a positive operating cash flow.
ALGRO.PA Yearly Net Income VS EBIT VS OCF VS FCFALGRO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1M -1M 2M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -4.55%
ROE -12.22%
ROIC N/A
ROA(3y)-0.82%
ROA(5y)0.31%
ROE(3y)-2.62%
ROE(5y)-0.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALGRO.PA Yearly ROA, ROE, ROICALGRO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Gross Margin of ALGRO has declined.
The Profit Margin and Operating Margin are not available for ALGRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.61%
GM growth 5YN/A
ALGRO.PA Yearly Profit, Operating, Gross MarginsALGRO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

More info and screens

3

2. Health

2.1 Basic Checks

ALGRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALGRO has about the same amout of shares outstanding than it did 1 year ago.
ALGRO has a better debt/assets ratio than last year.
ALGRO.PA Yearly Shares OutstandingALGRO.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ALGRO.PA Yearly Total Debt VS Total AssetsALGRO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ALGRO has an Altman-Z score of 1.85. This is not the best score and indicates that ALGRO is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.49 indicates that ALGRO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 1.85
ROIC/WACCN/A
WACC6.57%
ALGRO.PA Yearly LT Debt VS Equity VS FCFALGRO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

ALGRO has a Current Ratio of 1.60. This is a normal value and indicates that ALGRO is financially healthy and should not expect problems in meeting its short term obligations.
ALGRO has a Quick Ratio of 1.14. This is a normal value and indicates that ALGRO is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.14
ALGRO.PA Yearly Current Assets VS Current LiabilitesALGRO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

ALGRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17827.59%.
The Revenue has grown by 17.09% in the past year. This is quite good.
Measured over the past years, ALGRO shows a very strong growth in Revenue. The Revenue has been growing by 21.30% on average per year.
EPS 1Y (TTM)-17827.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-259.73%
Revenue 1Y (TTM)17.09%
Revenue growth 3Y21.3%
Revenue growth 5YN/A
Sales Q2Q%55.58%

3.2 Future

ALGRO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.23% yearly.
The Revenue is expected to grow by 7.39% on average over the next years.
EPS Next Y-66.67%
EPS Next 2Y52.75%
EPS Next 3Y44.23%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y8.17%
Revenue Next 3Y7.39%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALGRO.PA Yearly Revenue VS EstimatesALGRO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALGRO.PA Yearly EPS VS EstimatesALGRO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALGRO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALGRO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALGRO.PA Price Earnings VS Forward Price EarningsALGRO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.52
ALGRO.PA Per share dataALGRO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

ALGRO's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.75%
EPS Next 3Y44.23%

More info and screens

0

5. Dividend

5.1 Amount

ALGRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROLLEAU SACA

EPA:ALGRO (9/4/2025, 7:00:00 PM)

2.86

+0.02 (+0.7%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.12M
Analysts86.67
Price Target5.61 (96.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-26.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-350%
EPS NY rev (3m)-350%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-31.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF 15.27
P/B 0.68
P/tB 0.9
EV/EBITDA 8.52
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.19
OCFY6.55%
SpS14.04
BVpS4.21
TBVpS3.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.55%
ROE -12.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.31%
FCFM N/A
ROA(3y)-0.82%
ROA(5y)0.31%
ROE(3y)-2.62%
ROE(5y)-0.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.61%
GM growth 5YN/A
F-Score4
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 4.71
Cap/Depr 95.12%
Cap/Sales 4.69%
Interest Coverage N/A
Cash Conversion 42.66%
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.14
Altman-Z 1.85
F-Score4
WACC6.57%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)7.09%
Cap/Sales(5y)5.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17827.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-259.73%
EPS Next Y-66.67%
EPS Next 2Y52.75%
EPS Next 3Y44.23%
EPS Next 5YN/A
Revenue 1Y (TTM)17.09%
Revenue growth 3Y21.3%
Revenue growth 5YN/A
Sales Q2Q%55.58%
Revenue Next Year0%
Revenue Next 2Y8.17%
Revenue Next 3Y7.39%
Revenue Next 5YN/A
EBIT growth 1Y-2048.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1250%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.15%
OCF growth 3Y43.51%
OCF growth 5YN/A